- Home
- FDBC vs CATX Comparison
FDBC vs CATX Comparison
Compare FDBC & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDBC
- CATX
- Stock Information
- Founded
- FDBC 1902
- CATX 1983
- Country
- FDBC United States
- CATX United States
- Employees
- FDBC N/A
- CATX N/A
- Industry
- FDBC Major Banks
- CATX Medical/Dental Instruments
- Sector
- FDBC Finance
- CATX Health Care
- Exchange
- FDBC Nasdaq
- CATX Nasdaq
- Market Cap
- FDBC 234.2M
- CATX 239.0M
- IPO Year
- FDBC N/A
- CATX N/A
- Fundamental
- Price
- FDBC $43.95
- CATX $3.46
- Analyst Decision
- FDBC
- CATX Strong Buy
- Analyst Count
- FDBC 0
- CATX 11
- Target Price
- FDBC N/A
- CATX $12.90
- AVG Volume (30 Days)
- FDBC 5.7K
- CATX 703.2K
- Earning Date
- FDBC 10-22-2025
- CATX 08-13-2025
- Dividend Yield
- FDBC 3.64%
- CATX N/A
- EPS Growth
- FDBC 49.33
- CATX N/A
- EPS
- FDBC 4.10
- CATX N/A
- Revenue
- FDBC $84,975,000.00
- CATX $1,235,000.00
- Revenue This Year
- FDBC N/A
- CATX N/A
- Revenue Next Year
- FDBC N/A
- CATX N/A
- P/E Ratio
- FDBC $10.72
- CATX N/A
- Revenue Growth
- FDBC 20.65
- CATX N/A
- 52 Week Low
- FDBC $37.00
- CATX $1.60
- 52 Week High
- FDBC $61.21
- CATX $16.31
- Technical
- Relative Strength Index (RSI)
- FDBC 51.66
- CATX 45.68
- Support Level
- FDBC $42.24
- CATX $3.20
- Resistance Level
- FDBC $45.26
- CATX $3.68
- Average True Range (ATR)
- FDBC 1.50
- CATX 0.24
- MACD
- FDBC 0.10
- CATX -0.01
- Stochastic Oscillator
- FDBC 49.64
- CATX 40.00
About FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers. Company includes segments: Commercial and Industrial, Commercial Real Estate, Consumer, Residential Real Estate.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.